MyFinsight
Home
Blog
About
Back
Cash Flow
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)
source: myfinsight.com
Net increase
(decrease) in cash and cash...
-$9,181K
(-145.78%↓ Y/Y)
Non-refundable sublicense and
transition services...
$2,500K
(65.02%↑ Y/Y)
Share-based compensation
$525K
(-70.52%↓ Y/Y)
Prepaid research and
development
-$471K
(-813.64%↓ Y/Y)
Prepaid expenses and
other current assets,...
-$158K
(-127.67%↓ Y/Y)
Depreciation and
amortization
$25K
(-93.24%↓ Y/Y)
Net cash provided by
(used in) operating...
-$9,181K
(54.50%↑ Y/Y)
Canceled cashflow
$3,679K
Net loss
-$7,780K
Right of use assets and
operating lease...
$2,359K
(997.21%↑ Y/Y)
Net gain on lease
terminations
$1,977K
Accounts payable
-$408K
(-124.68%↓ Y/Y)
Accrued expenses and
other current...
-$328K
(87.55%↑ Y/Y)
Back